一项研究发现,使用尼基丁胺的退伍军人的皮肤癌发病率较低,特别是在诊断后不久就开始,但医生警告不要自我处方。 A study found that veterans taking nicotinamide had lower skin cancer rates, especially when starting soon after diagnosis, but doctors warn against self-prescribing.

对曾患过皮肤癌的退伍军人进行的一项大型研究发现,每天服用500毫克尼古丁胺两次与增加皮肤癌的风险降低14%有关,第一次诊断后开始服用的皮肤癌风险下降56%。 A large study of veterans with prior skin cancer found that taking 500 mg of nicotinamide twice daily was linked to a 14% lower risk of additional skin cancers, with a 56% reduction for those starting after their first diagnosis. 最大的好处是防止了细胞癌,尤其是在第一次皮肤癌后不久开始补充时。 The greatest benefit was seen in preventing cutaneous squamous cell carcinoma, especially when supplementation began soon after the first skin cancer. 没有发现心脏病风险增加。 No increased risk of heart problems was found. 虽然结果大有希望,但专家们告诫不要因剂量高而自我处方,建议咨询医生,并强调尼可辛胺不应取代防晒剂或防晒剂。 While the results are promising, experts caution against self-prescribing due to the high dose, recommend consulting a doctor, and emphasize that nicotinamide should not replace sunscreen or sun avoidance.